Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06023043 · ClinicalTrials.gov registry record · Phase 4

Postoperative Steroid Use in Adolescent Idiopathic Scoliosis and Neuromuscular Scoliosis Patients

A Phase 4 study, sponsored by Children's Hospital Los Angeles.

Not yet
Registry status
Phase 4
Development phase
100
Enrollment target

NCT06023043 is a Phase 4 study that has not yet begun recruiting, run by Children's Hospital Los Angeles. The registered enrollment target is 100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06023043, a Phase 4 study, has not yet begun recruiting, sponsored by Children's Hospital Los Angeles.

NOT YET RECRUITING
Registry status
Phase 4
Development phase
100 participants
Enrollment target

Study Summary

The goal of this randomized clinical trial is to compare the immediate use of steroids after surgery for accelerated discharge in adolescent idiopathic scoliosis and neuromuscular scoliosis after a posterior spinal fusion. The main question it aims to answer are: * What are the effects of using steroids immediately after surgery in decreasing opioid use and helping early mobilization(movement)? * Does post-operative steroid use affect the incidence of wound complications and are there any long-term impacts on scar formation? Participants will: * Fill out a Patient-Reported Outcomes Measurement Information System (PROMIS) survey specifically for pain interference and physical activity observing health related quality of life at enrollment, 3 months, 1 year, and 2 years * Have clinical photos of their incision at 3 months, 1 year, and 2 years * Their photos will be assessed using the stony book scar evaluation scale * For treatment of their scoliosis, patients will undergo a posterior spinal fusion (PSF) per standard of care, however whether the participant receives or does not receive steroids is what the investigators are trying to understand. * Researchers will compare no immediate postoperative steroid (NS) to the group with immediate postoperative steroid (WS) group to see if there are changes in opioid use, wound complications, scar formation, and facilitation in early mobilization.

Interventions

  • DRUG Dexamethasone

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-11-01
Est. Completion 2028-12-31
Phase Phase 4

Sponsor

Children's Hospital Los Angeles

119 total trials

What the Registry Record Tells You About NCT06023043

The ClinicalTrials.gov registry entry for NCT06023043 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Dexamethasone is the first listed.

NCT06023043 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06023043 about?

NCT06023043 is a clinical study titled "Postoperative Steroid Use in Adolescent Idiopathic Scoliosis and Neuromuscular Scoliosis Patients". The goal of this randomized clinical trial is to compare the immediate use of steroids after surgery for accelerated discharge in adolescent idiopathic scoliosis and neuromuscular scoliosis after a posterior spinal fusion. The main question it aims to answer are: * What are the effects of using st...

What is the current status of trial NCT06023043?

This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2025-11-01. Estimated completion is 2028-12-31.

What interventions are being tested in trial NCT06023043?

The interventions under investigation include: Dexamethasone (DRUG).

Who is sponsoring clinical trial NCT06023043?

This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.